UroGen Pharma URGN
NASDAQ URGN
$25.69 +0.37 (+1.46%)
As of: Nov 11, 2026 · 3:01 PM EST

UroGen Pharma (URGN) Return on Assets [ROA] (2017 - 2026)

Updated

UroGen Pharma's Return on Assets [ROA] came in at -38.57% for Q2 2026, up 29.35 percentage points from -67.92% a year earlier and up 20.10 percentage points from the prior quarter.

Analysis

UroGen Pharma (URGN) Return on Assets [ROA] (2017 - 2026) Analysis & Trends

For FY2025, UroGen Pharma's Return on Assets [ROA] was -63.14%, down 8.46 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of +16.07 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Assets [ROA] was -54.68% in FY2024 (+10.45 pp), -65.14% in FY2023 (+20.84 pp), -85.98% in FY2022 (+5.70 pp) and -91.68% in FY2021 (-12.47 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Assets [ROA] since Q2 2019.
  • Year-over-year, Return on Assets [ROA] increased in four of the last eight quarters, with an average year-over-year change of -3.83 percentage points.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q2 2024 (a gain of 57.61 percentage points), and the weakest in Q3 2025 (a drop of 44.10 percentage points).
  • Business Quant data shows URGN's Return on Assets [ROA] at -58.67% (Q1 2026), -79.63% (Q4 2025) and -83.62% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 UroGen Pharma 1.24 Bn 782.15 Mn 81.50 Mn -25.08%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -25.08%
Jun 30, 2026 -38.57%
Mar 31, 2026 -58.67%
Dec 31, 2025 -79.65%
Sep 30, 2025 -83.73%
Jun 30, 2025 -67.90%
Mar 31, 2025 -51.89%
Dec 31, 2024 -43.16%
Sep 30, 2024 -39.40%
Jun 30, 2024 -47.04%
Mar 31, 2024 -55.06%
Dec 31, 2023 -54.91%
Sep 30, 2023 -72.72%
Jun 30, 2023 -104.79%
Mar 31, 2023 -89.78%
Dec 31, 2022 -83.20%
Sep 30, 2022 -79.77%
Jun 30, 2022 -73.01%
Mar 31, 2022 -79.51%
Dec 31, 2021 -87.37%
API Access

UroGen Pharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=URGN&period=max&api_key=YOUR_API_KEY